Afobazol

Mild tranquilizer afobazol is a selective anxiolytic, not related to the class of receptor agonists benzodiazepin. Prevents the development of membranozavisimyh changes in GABA-receptor.

/

Has anxiolytic effect of activating a component, not accompanied by gipnosedative effect. A lack of preparation neuromuscular relaxant properties, negative impact on the performance of memory and attention. If its application is not a medication and does not develop syndrome cancel.

/

Effects of the drug is sold mainly in the form of a combination of anxiolytic and light activation effect. Reducing or eliminating anxiety, tension, inability to relax, insomnia, fear, somatics (muscle, sensory, cardiovascular, respiratory, gastrointestinal symptoms), vegetals (dry mouth, sweating, dizziness), cognitives (difficulty concentrating, weak memory) violations observed at 5-7 days of treatment afobazol. The maximum effect is achieved by the end of 4 weeks of treatment and remains in the posttherapeutic period, an average of 1-2 weeks. Especially shows the use of the drug in patients with predominantly asthenic personality traits as a disturbing valetudinarianism, insecurity, increased vulnerability and emotional lability, tendency to emotional and stress reactions.

/

Afobazol there was a positive influence on brain activity (often subjectively perceived the drug as a "light version phenibut"). To sum up - a few days (course afobazola since four weeks!) Is the effect, if afobazol - a lightweight, unobtrusive, no side effects, with some improvement in the subjective sensations in the head and body - not a placebo because the help and those in anyone with circulatory problems of the brain, they say, that occur soon after taking edakie "goose" pleasing to the head. Soft drug to his patient ... and cheap!